Abstract

In this study published in Urologic Oncology , Waingankar and the group form Mount Sinai (1) perform an analysis on the impact of pathological complete response to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC) on conditional surviving, meaning the updated probability of surviving after having survived each additional year after the treatment.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.